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Chapter 1. Introduction 
 
1.1 The human retina 
 
The anatomy of the human retina, as well as that of other non-human primates, 
gives priority to high transparency and photoreceptor density. The retinal supply and 
oxygenation are sparse compared with the rate of oxygen consumption. 
Phototransduction and neural signaling are energy-consuming processes and have 
presumably developed in response to an evolutionary pressure for high-performance 
vision. The arrangement and anatomy of human retina is built around this critical 
function of high-acuity, high-performance vision. 
The human retina is approximately 0.2 mm thick, and has an area of 
approximately 1100 mm2. Each retina possesses about 200 million neurons. The optic 
disc, where neuronal cells merge to form the optic nerve, is the only area of the retina 
that is “blind” as it lacks photoreceptors. It appears as an oval white area of 3 mm2. 
Temporal to this disc is the macula. At its center is the fovea, a pit that is most 
sensitive to light and is responsible for the sharp central vision. Humans possess only 
one fovea. Around the fovea extends the central retina for about 6 mm and then the 
peripheral retina. The edge of the retina is defined by the ora serrata. The length from 
one ora to the other (or macula), the most sensitive area along the horizontal meridian 
is about 3.2 mm. 
The retina consists of three major types of cells: neurons, glial cells and blood 
vessels and most, if not all, of these cell types are affected to some degree in many 
retinal diseases including age-related macular degeneration. Retina is primarily a 
neuronal tissue. Indeed, neurons and glial cells comprise about 95%of the retinal 
mass. The glial cells of the retina, Müller cells and astrocytes, serve as support cells 
for the neurons and blood vessels. 
The whole retina is frequently described as having ten layers (Figure 1), which 
are: 
1. The internal limiting membrane. 
2. The stratum opticum, or nerve fiber layer (NFL). 
3. The ganglion cell layer. 
4. The inner plexiform layer (IPL). 
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5. The inner nuclear layer (INL). 
6. The outer plexiform layer (OPL). 
7. The outer nuclear layer (ONL). 
8. The external limiting membrane. 
9. The layer of rods and cones. 
10. The retinal pigment epithelium (RPE). 
 
 
Figure 1 – Cross section of the human retina. A scheme of a retinal cross section showing the different 
retinal cells is shown (from Wolff, 1976). 
 
 
1.1.1 Photoreceptor cells 
 
The photoreceptor cells of the retina consist of the rods and cones. These are 
the primary neurons in the visual pathway. The photoreceptors differentiate 
longitudinally into two major divisions that extend from their cell body: the inner and 
outer segments. The inner segment contains the metabolic apparatus, while the outer 
segment’s major function is the conversion of light into neuroelectrical energy. 
Histologically, the photoreceptors are classified into two types: rods and cones. The 
cones are present predominantly in the foveal region, whereas the rods are more 
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common at the periphery of the retina. Rods are responsible for sensing motion, 
contrast and brightness, while cones are necessary for color vision, fine detail 
perception and spatial resolution. In order to maintain the photoreceptor excitability, 
the outer segments are shed from the photoreceptors, allowing a constant renewal of 
photoreceptor outer segments (POS) (Young, 1967; Young and Droz, 1968; Young 
and Bok, 1969; Young, 1976; Bok, 1993; Nguyen-Legros and Hicks, 2000; Strauss, 
2005). Cell bodies of rods and cones are connected to specialized synaptic terminals 
known as spherules and pedicles, respectively. 
 
1.1.2 Bipolar cells 
 
The bipolar cells in the retina constitute the second retinal neuron, connecting 
the photoreceptors to the ganglion cells. With their cell bodies in the INL, bipolar 
cells extend from the outer to the inner plexiform layer. In the foveal region, bipolar 
cells may receive input from just one cone, while in the periphery of the retina one 
bipolar cell can receive stimuli from up to 50-100 rods. 
 
1.1.3 Horizontal cells 
 
The horizontal cells receive their name because of the very broad horizontal 
extension of their processes. The two different types of horizontal cells, small field 
and large field, share the common anatomical feature of having their dendrites 
synapse only with cone pedicles while their axons synapse only with rod spherules. 
Each rod receives input from at least two different horizontal cells. Although the 
horizontal cells lie primarily in the outer lamina of the INL, they are present in almost 
all areas of the retina. However, they are absent in the fovea and parafoveal regions. 
 
1.1.4 Amacrine cells 
 
The amacrine cell bodies are located in the innermost zone of the INL. There 
are none in the fovea, while in the retinal periphery they constitute the majority of 
cells in the internal lamina of the INL. A considerably variety of types have been 
identified in the human retina. These have been named stratified and diffuse, the chief 
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criterion of differentiation being in the mode of arborization of their single process. 
Stratified subpopulations of amacrine cells have different connections within the 
retinal circuits, playing different modulatory roles in the physiological output of the 
retina (Strettoi and Masland, 1996). 
 
1.1.5 Ganglion cells 
 
The ganglion cell bodies form the distinct layer that lies external to the nerve 
fiber layer and internal to the IPL. All the axons from the ganglion cells merge to 
form the optic nerve, which has been shown to have approximately the same number 
of medullated nerve fibers, as there are ganglion cells. While ganglion cells form a 
six- to eight-cell-thick layer at the macula, there are no ganglion cells at the fovea or 
at the optic nervehead.  
There are many forms of ganglion cells. All share the basic function of 
transmitting a signal from the bipolar cell to the lateral geniculate body. Variations 
among the ganglion cells are based on size, degree of arborization, spread of their 
dendritic processes into the bipolar synaptic field and their pattern of synaptic 
connections with amacrine cells. These anatomical differences among ganglion cells 
have been shown to correlate with their electrophysiologic functional specificity.  
 
1.1.6 Müller cells 
 
The Müller cells are the principal glial cells that maintain the structure of the 
retina. They are the largest cells in the retina, and with their shape similar to columnar 
epithelial cells, they extend all the way from the external to the internal limiting 
membrane. The Müller cells form tight junctions on contact both with other Müller 
cells and with neural cells. Here, the Müller cells form the external limiting 
membrane by a continuous even row of zonulae adherentes. This row of junctions 
constitutes a barrier to the passage of metabolites in and out of the retina.  
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1.1.7 Astrocytes 
 
Although the Müller cells constitute the majority of retinal glial cells, the 
astrocytes (astroglia) are widely dispersed between the vasculature and the neurons. 
Morphological and cytoplasmic features of these cells allow them to be categorized 
into fibrous astrocytes, protoplasmic astrocytes and lemnocytes (Hogan and Feeney, 
1963). Their pedicles are believed to constitute an important functional component of 
the blood-retinal barrier. 
 
1.1.8 Microglia 
 
The microglia distributes itself primarily to follow the two main capillary 
plexuses of the retina – one near the horizontal cells and the other near the amacrine 
cells. However, other microglial cells are found in all layers. It is not known whether 
these scavenger cells are present in the normal retina. It is possible that they enter the 
retina only after damage. Rather than playing a structural role, as does other glia, 
microglial cells play an active role in phagocytosis and destruction of phagocytozed 
material. In addition to this, microglial cells release proinflammatory mediators in 
response to a variety of stresses (Krady et al., 2005). The microglia has, therefore, an 
important immunomodulatory role in the retina. 
 
1.1.9 Retinal vasculature 
 
The retina is unique in having the highest oxygen consumption per unit weight 
of any tissue in the human body. In fact, as Otto Warburg first reported in 1928, when 
normalized for its weight, the retina has an oxygen consumption ~50% higher than 
the brain or kidney (Warburg, 1928). To meet this metabolic demand, the retina has 
two separate circulatory systems. While the choroidal circulation nourishes its outer 
third, the inner two-thirds receive nutrition from the retinal circulation. These two 
systems have distinctly different anatomical and physiologic attributes. While the 
choroidal circulation is a high-flow and variable-rate circulation with free transfer of 
metabolites of all sizes between it and the surrounding tissues, the retinal circulation 
is a lower but more constant flow system with a higher rate of oxygen extraction. The 
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choroidal circulation functions as both a nutritive and cooling system for the eye, 
while the retinal circulation serves only the nutritive function for the inner two-thirds 
of the retina (Jakobiec, 1982). 
Most of the oxygen consumption in the retina occurs in photoreceptors. One 
drawback of this vascular arrangement, at least on a timescale of decades, is that it 
constitutively exposes the retinal pigment epithelium and the distal outer segments to 
an oxygen concentration roughly equivalent to that found in arterial blood 
(Linsenmeier and Steinberg, 1986). This results in the accumulation of oxidative and 
photooxidative damage, the latter reflecting the unique vulnerability of the retina as 
the only neural tissue that is exposed directly to light and hence to chemically reactive 
oxygen species (ROS) generated by light absorption (Rattner and Nathans, 2006).  
 
1.1.10 The retinal pigment epithelium (RPE) 
 
The RPE is a monolayer of pigmented cells and forms part of the blood-retinal 
barrier (BRB) (Bok, 1993; Rizzolo, 1997; Marmorstein, 2001). The apical membrane 
of the RPE faces the photoreceptor outer segments, whereas its basolateral membrane 
faces Bruch’s membrane, a semi-permeable exchange barrier that separates the RPE 
from the choroid (Strauss, 2005). 
 
 
 
Figure 2 - Summary of retinal pigment epithelium (RPE) functions. PEDF, pigment epithelium-
derived growth factor; VEGF, vascular epithelium growth factor; Epithel, epithelium. Adapted from 
(Strauss, 2005). 
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The RPE is essential for visual function, providing multiple functions that 
support normal photoreceptor function (Figure 2). In fact, the RPE and photoreceptors 
are together considered a functional unit. Mutations in genes that are expressed in the 
RPE, such as MerTK or RPE65, can lead to photoreceptor degeneration. On the other 
hand, mutations in genes expressed in photoreceptors, such as ABCR, can lead to 
degenerations of the RPE (Strauss, 2005). 
The RPE pigmentation absorbs the light energy focused by the lens on the 
retina (Bok, 1993; Boulton and Dayhaw-Barker, 2001; Strauss, 2005).  
The RPE transports ions, water, and metabolic end products from the 
subretinal space to the blood and takes up nutrients such as glucose, retinol and fatty 
acids from the blood, delivering them to photoreceptors (Strauss, 2005). 
The RPE also plays an important role in the visual cycle of retinal. 
Photoreceptors lack cis-trans isomerase function for retinal and are unable to 
reisomerize all-trans-retinal, formed after photon absorption, back into 11-cis-retinal. 
To maintain the photoreceptor excitability, retinal is transported to the RPE, 
reisomerized to 11-cis-retinal and transported back to photoreceptors (Baehr et al., 
2003; Besch et al., 2003; Thompson and Gal, 2003; Strauss, 2005). Furthermore, the 
voltage-dependent ion conductance of the apical membrane enables the RPE to 
stabilize ion composition in the subretinal space, which is essential for the 
maintenance of photoreceptor excitability (Steinberg et al., 1983; Steinberg, 1985; 
Strauss, 2005). Another function in the maintenance of photoreceptor excitability is 
the phagocytosis of shed photoreceptor outer segments (Bok, 1993; Strauss, 2005). 
Photoreceptors are exposed to intense levels of light. This leads to accumulation of 
photo-damaged proteins and lipids. In addition, retinal itself can generate photo-
oxidative radicals (Strauss, 2005). Thus, the concentration of light-induced toxic 
substances inside the photoreceptors increases over time (Beatty et al., 2000; Strauss, 
2005). To maintain the excitability of photoreceptors, the POS undergo a constant 
renewal process (Young, 1967; Young and Droz, 1968; Young and Bok, 1969; 
Young, 1976; Bok, 1993; Nguyen-Legros and Hicks, 2000; Strauss, 2005). In this 
renewal process, POS are newly built from the base of outer segments, at the cilium. 
The tips of the POS that contain the highest concentration of radicals, photo-damaged 
proteins and lipids are shed from the photoreceptors (Strauss, 2005). Through 
coordinated POS tip shedding and formation of new POS, a constant length of the 
POS is maintained. Shed POS are phagocytozed by the RPE. In the RPE, shed POS 
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are digested and important molecules, such as retinal or docosahexaenoic acid, are 
recycled and delivered back to photoreceptors in a manner comparable to the visual 
cycle (Bibb and Young, 1974; Strauss, 2005). The process of disk shedding and 
phagocytosis must be tightly coordinated between the RPE and the photoreceptors. A 
failure in this regulation would result in POS that are either too long or too short 
(Strauss, 2005). 
In addition to these functions, the RPE is known to produce and to secrete a 
variety of growth factors, as well as factors that are essential for maintenance of the 
structural integrity of the retina and choriocapillaris (Witmer et al., 2003; Strauss, 
2005). The RPE produces factors that support survival of photoreceptors and ensure a 
structural basis for optimal circulation and supply of nutrients. This secretory activity 
of the RPE also plays an important role in establishing the immune privilege of the 
eye by secreting immunosuppressive factors (Streilein et al., 2002; Strauss, 2005).  
Altogether, RPE cells perform a variety of complex functions in the retina. 
Therefore, it is not surprising that deregulation of the RPE has a critical impact on 
retinal function and may lead to loss of visual function and loss of vision.  
 
1.2 Age-related macular degeneration 
 
Age-related macular degeneration (AMD) is the leading cause of blindness in 
the western world in the population over 60 years of age (Beatty et al., 2000; Rattner 
and Nathans, 2006), and its prevalence is likely to rise as a consequence of increasing 
longevity (Beatty et al., 2000). 
AMD is characterized by degenerative changes in the macula, the central 
region of the retina bearing the highest concentration of photoreceptors. Accordingly, 
this degeneration of the macula leads to loss of central vision. The earliest clinical 
manifestation and pathological feature of AMD is the formation of drusen, 
extracellular deposits of glycoproteins, lipids, and cellular debris located between 
Bruch’s membrane and the RPE (Ambati et al., 2003a; Rattner and Nathans, 2006; 
Patel and Chan, 2008). A few small drusens can be found in healthy individuals over 
the age of 50, but the presence of large or numerous drusen confers significant risk for 
AMD (Klein et al., 1992; Klein et al., 1997).  
Clinically and histologically, AMD is generally classified into two major 
subtypes: dry AMD and wet AMD (Figure 3). Dry AMD progresses more slowly and 
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manifests with drusen, geographic atrophy of RPE, and photoreceptor dysfunction 
and degeneration. Wet AMD, on the other hand, is more debilitating and often 
follows after dry AMD. The key feature of wet AMD is choroidal neovascularization 
(CNV), the growth of new blood vessels from the choroid into the region underlying 
the RPE or extending past the RPE into the subretinal space and retina. This choroidal 
neovascularization can lead to leakage of blood into the subretinal space, which, 
along with RPE atrophy and photoreceptor degeneration, leads to vision loss (Ambati 
et al., 2003a; Rattner and Nathans, 2006; Patel and Chan, 2008). 
 
 
 
Figure 3 – Comparison between the dry and wet forms of Age-Related Macular Degeneration (AMD) 
(adapted from National Eye Institute, National Institutes of Health1). 
 
 
Risk factors for AMD include smoking, body mass index, diet, and light 
exposure. A number of studies have linked genetics, oxidative stress, RPE 
senescence, hypoxia, and many other factors to AMD. Still, the exact etiology and 
pathogenesis of the disease remain largely unclear (Taylor et al., 1990; Beatty et al., 
2000; Ambati et al., 2003a; Clemons et al., 2005; Scholl et al., 2007) 
 
 
 
 
 
 
                                                
1 http://www.nei.nih.gov 
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1.2.1 Oxidative stress and age-related macular degeneration 
 
Oxidative stress, which refers to cellular damage caused by reactive oxygen 
species (ROS), has been implicated in many diseases, including age-related macular 
degeneration (Beatty et al., 2000; Liang and Godley, 2003). ROS include free 
radicals, hydrogen peroxide, and singlet oxygen.  
An increasing body of literature indicates that development of AMD is related 
to dysfunction of the RPE (Boulton et al., 2004; Zarbin, 2004; Zhou et al., 2005). 
This dysfunction may be related with the higher susceptibility of the RPE to oxidative 
stress. In fact, a variety of studies suggest that RPE cells can be readily damaged 
following exposure to an oxidative insult (Beatty et al., 2000; Liang and Godley, 
2003). 
 The retina is an ideal environment for the generation of ROS for several 
reasons. The oxygen consumption by the retina is much higher than by any other 
tissue. Physiologically, RPE cells phagocytose and digest POS. This unique 
phagocytic function of RPE provides an additional oxidative burden since the shed 
outer segments are extremely rich in polyunsaturated fatty acids (PUFA), which can 
be readily oxidized and which can initiate a cytotoxic chain-reaction, producing an 
abundance of ROS. In fact, the process of phagocytosis by the RPE is itself an 
oxidative stress and results in the generation of ROS (Beatty et al., 2000; Liang and 
Godley, 2003). 
Age-related accumulation of lipofuscin in RPE is another source of oxidative 
stress. Lipofuscin is a mixture of non-degradable protein-lipid aggregates derived 
from the ingestion (phagocytosis) of POS (Sparrow and Boulton, 2005). A2E is the 
major fluorophore of lipofuscin and acts as a photosensitizer to generate ROS inside 
the cells upon exposure to blue light (Rozanowska et al., 1995; Rozanowska et al., 
1998; Sparrow and Boulton, 2005). 
Consistent with a role of oxidative stress in the development of AMD, several 
studies indicate that exposure of RPE cells to oxidative stress results in an increase of 
angiogenic cytokines and growth factors, as well as in phenotypes associated with 
development of AMD (Higgins et al., 2003; Schlingemann, 2004; Zhou et al., 2005; 
Kannan et al., 2006). 
 To cope with these toxic oxygen species, the RPE has three lines of defense 
(Boulton and Dayhaw-Barker, 2001). The first line is absorption and filtering of light. 
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The RPE contains a complex composition of various pigments that are specialized to 
absorb different wavelengths (Beatty et al., 1999; Beatty et al., 2000; Beatty et al., 
2001). General light absorption occurs via melanin in melanosomes. Photoreceptors 
also absorb light and contain important pigments such as the carotenoids lutein and 
zeaxanthin (Handelman et al., 1988; Handelman et al., 1992; Bone et al., 1997; 
Landrum et al., 1999). These pigments have a protective function by absorbing blue 
light (Beatty et al., 1999; Beatty et al., 2000; Beatty et al., 2001). The second line of 
defense is made by antioxidants, both enzymatic and nonenzymatic. For example, the 
RPE contains high amounts of superoxide dismutase (Newsome et al., 1990; Miceli et 
al., 1994; Frank et al., 1999) and catalase (Miceli et al., 1994; Tate et al., 1995). The 
RPE also accumulates carotenoids, such as lutein and zeaxanthin (Beatty et al., 2000; 
Beatty et al., 2001), ascorbate, -tocopherol, and -carotene (Beatty et al., 2000), 
which are nonenzymatic antioxidants. In addition, RPE cells contain glutathione and 
melanin, which itself can function as an antioxidant. The third line of defense is the 
cell’s physiological ability to repair damaged DNA, lipids and proteins (Strauss, 
2005). 
However, with increasing age, the RPE antioxidant capability appears to 
diminish. In fact, an age-dependent reduction in -tocopherol, one of the most 
important antioxidants, and melanosomes has been reported in the RPE (Feeney, 
1978; Feeney-Burns et al., 1984; Friedrichson et al., 1995). Thus, it is likely that 
aging RPE cells are more susceptible to oxidative damage (Liang and Godley, 2003). 
In support of this hypothesis, recent studies have shown that mice deficient in Cu, Zn-
superoxide dismutase, an antioxidant enzyme, display features typical of AMD in 
humans (Imamura et al., 2006; Justilien et al., 2007; Dong et al., 2009). 
 
1.2.2 Inflammation and age-related macular degeneration 
 
 Emerging pathological evidence indicates that many age-related diseases such 
as AMD, atherosclerosis, arthritis and certain types of cancer are associated with an 
inflammatory component (Lavrovsky et al., 2000; Zarbin, 2004; McGeer et al., 2005; 
Chung et al., 2006; Donoso et al., 2006; Moshfeghi and Blumenkranz, 2007). The 
activation of redox-sensitive transcription factors may be involved in triggering the 
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expression of proinflammatory cytokines, thus providing a link between oxidative 
stress and inflammation upon aging (Lavrovsky et al., 2000; Chung et al., 2006). 
 The complement system is a central part of innate immunity and in its normal 
setting is aimed at recognizing and eliminating invading microorganisms. The 
complement system is divided into three main pathways: classical, lectin and 
alternative. The classical pathway is activated largely by immune complexes 
(antibody-antigen complex); the mannose-binding lectin pathway is activated 
primarily by mannose and N-acetyl glucosamine residues that are abundant on 
bacterial cell surfaces and the alternative pathway is initiated by a variety of 
activating substances including microbial surfaces and polysaccharides. The 
activation of these pathways results in a proinflammatory response including 
generation of a membrane attack complex (MAC), which mediates cell lysis, release 
of chemokines to attract neutrophils and macrophages to the site of damage, and 
enhancement of capillary permeability (Walport, 2001a, 2001b; Patel and Chan, 
2008). A deregulation of the complement, particularly the alternative pathway, results 
in defective recognition of microorganisms (or other toxic agents) and leads to an 
accumulation of toxic activation products (Zipfel et al., 2006).  
Several studies have suggested a role for the complement system in AMD. 
Components of the complement, such as C5 and MAC consisting of C5b-9, have been 
identified in drusen from human eyes, including eyes of patients with AMD (Mullins 
et al., 2000). In addition, C3a and C5a have been localized to drusen, RPE cells and 
Bruch’s membrane in human AMD (Nozaki et al., 2006; Patel and Chan, 2008). 
Other studies have demonstrated the presence of immune complexes, complement, 
and/or complement regulatory proteins in drusen and RPE (Hageman et al., 1999; 
Johnson et al., 2000; Johnson et al., 2001; Crabb et al., 2002; Patel and Chan, 2008). 
Complement factor H (CFH) is a negative regulator of the complement 
system. CFH acts by inhibiting several steps of the alternative pathway and by 
promoting degradation of activated complement components (Alsenz et al., 1985; 
Patel and Chan, 2008). CFH binds heparin on cell surfaces to prevent complement-
mediated damage to heparin and the cells bearing them. It also binds C-reactive 
protein (CRP) to inhibit CRP-mediated activation of the alternative pathway in 
response to damaged tissue (Rodriguez de Cordoba et al., 2004; Prosser et al., 2007; 
Patel and Chan, 2008). Recent studies have shown that polymorphisms in CFH and 
complement Factor B (CFB), a positive regulator of the alternative pathway of the 
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complement, are strongly associated with increased risk to develop AMD (Edwards et 
al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Gold et al., 
2006), highlighting the role of the complement in the pathogenesis of this disease. 
Interestingly, a recent report suggests that oxidative stress in RPE can trigger 
the activation of the complement (Zhou et al., 2006). Moreover, complement 
activation is associated with enhanced expression of interleukin-8 (IL-8) (Fukuoka 
and Medof, 2001; Fukuoka et al., 2003). IL-8 is an important inflammatory and 
angiogenic cytokine (Brat et al., 2005) and its increased expression has also been 
reported in RPE cells that were fed with oxidized POS (Higgins et al., 2003), 
supporting the link between oxidative stress and inflammation. The increased 
expression and secretion of IL-8 may account, at least in part, for the inflammatory 
reactions during development of AMD (Higgins et al., 2003; Kalayoglu et al., 2005). 
 In addition, there is further evidence, including animal models of disease, for 
the involvement of inflammation in the pathogenesis of AMD. Monocyte 
chemoattractant protein-1 (MCP-1) is a chemokine involved in macrophage 
infiltration into sites of inflammation (Oppenheim et al., 1991). In RPE, this 
chemokine has been suggested to play a role in drusen clearance (Duvall and Tso, 
1985). A recent study showed that deficiency in MCP-1 or its cognate receptor Ccr-2 
causes AMD-like features in mice, including accumulation of lipofuscin and drusen 
beneath the RPE, photoreceptor atrophy and choroidal neovascularization (CNV) 
(Ambati et al., 2003b). The impaired macrophage recruitment results in the 
accumulation of complement components, such as complement regulatory proteins 
and IgG in the retina. Because deposition of complement-related proteins and IgG 
precedes the accumulation of drusen and lipofuscin, it is likely that the AMD-like 
pathology is due, at least in part, to complement activation and immune complex 
deposition (Ambati et al., 2003b).  
On the other hand, several studies have demonstrated accumulation of 
macrophages in histologic specimens from patients with AMD, especially in regions 
of RPE atrophy, breakdown of Bruch’s membrane and CNV (Lopez et al., 1991; 
Dastgheib and Green, 1994; Penfold et al., 2001; Grossniklaus et al., 2002). This 
macrophage accumulation may serve a pathological role in AMD (Kamei et al., 
2007). 
Therefore, it is still quite unclear whether macrophages play a pathologic or a 
restorative/adaptive role in AMD. 
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1.3 The Ubiquitin Proteasome Pathway 
 
The ubiquitin- proteasome pathway (UPP) is a major proteolytic pathway 
present in virtually every eukaryotic cell where it regulates vital biological and 
physiological processes. Cellular processes such as cell division, differentiation, 
signal transduction, quality control and protein trafficking are all regulated to some 
extent by the UPP (Glickman and Ciechanover, 2002; Ciechanover, 2003; Shang and 
Taylor, 2004; Welchman et al., 2005). The importance of UPP in normal physiology 
is tremendous and disruption of components of UPP has been implicated in a great 
variety of human diseases, including age-related diseases such as Alzheimer’s disease 
(Hope et al., 2003), Parkinson’s disease (Dawson and Dawson, 2003), diabetic 
retinopathy (Fernandes et al., 2006) and cataract (Jahngen-Hodge et al., 1992a; Shang 
et al., 1997a; Shang et al., 2001b; Dudek et al., 2005). 
There are numerous forms of ubiquitin and ubiquitin-like proteins present in 
the cells. In fact, more than 10 ubiquitin-like modifiers have been identified to date 
(Kerscher et al., 2006). Ubiquitin was described as “Darwin’s phosphate” (R. 
Hampton, FASEB meeting 2001, Vermont, USA) and the total number of genes 
involved in ubiquitin and ubiquitin-like reactions is comparable to the number of 
genes involved in phosphorylation/dephosphorylation reactions (Lorick et al., 2005). 
Although this was initially recognized as a selective degradation pathway, more 
recent evidence showed that UPP has a number of non-degradative functions 
(Welchman et al., 2005) that have a significant role in numerous biological processes 
and that are also implicated in a number of human diseases. 
 
1.3.1 Ubiquitin-dependent Protein Degradation 
 
Degradation of a protein by the UPP involves two discrete and successive 
steps: first, the substrate is tagged by covalent attachment of multiple ubiquitin 
molecules. In a second stage, the polyubiquitinated protein is degraded by the 26S 
proteasome complex with the release of free ubiquitin that can be used in subsequent 
ubiquitination cycles (Pickart, 2001a; Glickman and Ciechanover, 2002). Removal of 
ubiquitin from substrates prior to degradation is also a regulated process that is carried 
out by deubiquitinating enzymes (Pickart, 2001a; Glickman and Ciechanover, 2002). 
Ubiquitin is a small peptide of 76 aminoacids, which is highly conserved from yeast 
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to humans. Indeed, there are only three aminoacid substitutions between yeast and 
human ubiquitin (P19S, E24D, A28S). This makes ubiquitin the most highly 
conserved protein identified in eukaryotes so far (Ozkaynak et al., 1984).  
Conjugation of ubiquitin to substrates proceeds via a three-step mechanism. 
Initially, the ubiquitin-activating enzyme (E1) activates ubiquitin in an ATP-
dependent reaction to generate a high-energy thiol ester intermediate. In the second 
step, one of a variety of ubiquitin conjugating enzymes (E2) transfers the activated 
ubiquitin moiety from the E1 to the substrate that is generally associated to one of a 
member of the ubiquitin ligase family (E3) (Figure 4). In some cases, ubiquitin can be 
transferred from the E2 to the E3 and subsequently from the E3 to the substrates 
(Pickart, 2001a; Glickman and Ciechanover, 2002). This sequence of reactions is 
repeated until a chain of typically four or more ubiquitins is attached to the substrate 
(Beal et al., 1996b; Pickart, 1997b; Lam et al., 2002b). The most common and best-
characterized fate of a polyubiquitinated protein is its translocation to a large 
proteolytic complex, the 26S proteasome, where it is degraded. Although this is the 
canonical view of the system and indeed, the process responsible for the degradation 
of numerous cytosolic proteins, it should be emphasized that sometimes only one 
ubiquitin is attached to the protein in one or more aminoacid residues. This results in 
the production of a monoubiquitinated protein. Proteins can be monoubiquitinated in 
different residues resulting in the formation of a multi-monoubiquitinated protein 
(Hicke and Dunn, 2003; Haglund and Dikic, 2005). In most cases the final destination 
of such proteins is not degradation but rather targeting to specific subcellular 
compartments, including the endocytic pathway (Hicke and Dunn, 2003; Haglund and 
Dikic, 2005). 
 The formation of a polyubiquitinated protein is generally initiated by the 
formation of an isopeptide bond between the C-terminus of the last glycine residue of 
ubiquitin (G76) and the NH2 group of an internal lysine residue in the substrate, to 
generate a covalent isopeptide bond (Glickman and Ciechanover, 2002). Less 
frequently, ubiquitin can be conjugated to the terminal NH2 group of the substrate 
(Ciechanover and Ben-Saadon, 2004). 
The subsequent addition of other ubiquitin molecules involves frequently (but 
not always) the formation of a peptide bond between the G76 at the C-terminus of a 
newly activated ubiquitin and the lysine 48 of the previously attached ubiquitin 
molecule. This sequence of reactions leads to the formation of polyubiquitin chains of 
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different sizes (Pickart, 1997b). The polyubiquitin chain is, then, recognized by the 
26S proteasome and the substrate is degraded. As the substrate is unfolded and enters 
the pore of the catalytic chamber of the 20S proteasome, deubiquitinating enzymes 
present in the 19S caps of the proteasome remove polyubiquitin chains from the 
substrates, thus regenerating free ubiquitin (DeMartino and Slaughter, 1999; Pickart 
and Cohen, 2004; Demartino and Gillette, 2007). 
 
 
 
Figure 4 - The ubiquitin–proteasome pathway (UPP). A cascade of enzymatic reactions leads to 
ubiquitination of lysine residues of the substrate. Adapted from (Meusser et al., 2005). 
 
 
Ubiquitin contains seven lysine residues (Lys6, Lys11, Lys27, Lys29, Lys33, 
Lys48 and Lys63) and all of them can be used for chain formation, resulting in 
ubiquitin chains of different lengths and shapes in vitro and in vivo (Johnson et al., 
1995; Peng et al., 2003; Pickart and Fushman, 2004; Kim et al., 2007; Ikeda and 
Dikic, 2008). Whereas Lys48-linked polyubiquitin chains are well established as a 
signal for targeting substrates to the 26S proteasome (Glickman and Ciechanover, 
2002; Pickart and Fushman, 2004), Lys63-linked chains are involved in 
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nonproteolytic events, such as DNA repair, signal transduction and receptor 
endocytosis in vivo (Pickart and Fushman, 2004; Haglund and Dikic, 2005; Chen and 
Sun, 2009). Nevertheless, some studies suggest that Lys63-linked polyubiquitin 
chains may support proteasomal degradation in vitro (Hofmann and Pickart, 2001; 
Kim et al., 2007; Saeki et al., 2009). However, the in vivo significance of these 
observations is still poorly understood. Much less is known about the roles of 
unconventional polyubiquitin chains linked through Lys6, Lys11, Lys27, Lys29 or 
Lys33. Polyubiquitin chains linked via Lys6, Lys11 or Lys48 all bind to the 
proteasomal subunit Rpn10/S5a with similar affinities (Baboshina and Haas, 1996), 
suggesting that these chains may play a role in proteasomal degradation. In fact, 
recent studies imply that Lys11-linked chains are involved in proteasome-dependent 
protein degradation of cell cycle regulators (Kirkpatrick et al., 2006; Jin et al., 2008) 
and endoplasmic reticulum-associated degradation (ERAD) substrates (Xu et al., 
2009). Lys6 linkages catalyzed by the BRCA1/BARD1 E3 may regulate DNA repair 
(Nishikawa et al., 2004). Both Lys27 and Lys33 may be built during stress response 
by U-box-type E3 ligases (Hatakeyama et al., 2001). Lys29-linked chains may be 
important in ubiquitin fusion degradation (Johnson et al., 1995). 
The specificity and selectivity of the UPP was unclear for many years and 
some specific aspects of the system selectivity still remain to be elucidated. It is 
currently accepted that the high selectivity of the system is primarily the result of the 
presence of specific signals in substrate proteins and the action of both ubiquitin 
ligases (E3s) and related ancillary proteins (Glickman and Ciechanover, 2002). In 
most instances, substrates are not constitutively nor directly recognized by ligases. In 
some cases, the ligase must be activated by undergoing some posttranslational 
modification to yield an active form that recognizes the substrates. In other instances, 
it is the substrate that must undergo specific modifications that renders it a target for 
ubiquitination (Glickman and Ciechanover, 2002). Ubiquitin ligases are therefore key 
players in determining the system specificity. The first E3s to be identified were very 
diverse and apparently unrelated. The first big family of E3s to be recognized 
presented a 350-aminoacid residue sequence Homologous to E6-AP (E6-Associated 
Protein) Carboxyl Terminus and are currently known as HECT domain E3s 
(Huibregtse et al., 1995). This domain contains a conserved cysteine residue to which 
the ubiquitin moiety is transferred from E2s (Scheffner et al., 1995). The first ligase 
of the HECT domain family to be identified was E6-AP. E6 is the oncoprotein of the 
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high-risk human papillomaviruses (HPVs). The E6 oncoprotein binds to the cellular 
ubiquitin ligase E6-AP and targets the tumour suppressor protein p53 for rapid 
degradation (Scheffner et al., 1993) rendering cells more susceptible to tumour 
development. In the absence of the viral ancillary protein, E6-AP targets other cellular 
proteins for degradation. However, the physiological relevance of these interactions 
remains to be shown (Scheffner and Staub, 2007). Mutations in E6-AP are implicated 
in diseases such as Angelman syndrome, a severe form of mental and motor 
retardation (Kishino et al., 1997). Other important members of the HECT domain 
family of ubiquitin ligases include NEDD4, Npi1/Rsp5, Smurf1 and Smurf2 
(Scheffner and Staub, 2007).  
Virtually all ubiquitin ligases, or E3s, that do not belong to the HECT domain 
family, belong to the large family of RING (Really Interesting New Gene) finger 
proteins (Glickman and Ciechanover, 2002; Pickart, 2004). The mammalian RING 
finger domain family is very large and it is currently accepted that many of its 
members are, indeed, E3s (Lorick et al., 1999). RING fingers consist of domains of 
approximately 70 aminoacid residues containing a pattern of conserved cysteine and 
histidine residues that bind zinc and stabilize the typical globular conformation of 
these proteins (Lovering et al., 1993). Interestingly, it is the spacing of zinc ligands, 
rather than any primary sequence, that is conserved in the RING finger family, 
suggesting that RING fingers are likely to function as structural elements in a 
complex, rather than presenting catalytic activity (Pickart, 2001a). Indeed, it was 
shown that unlike HECT domain E3s, RING fingers proteins do not have a catalytic 
function in the ubiquitination process (Glickman and Ciechanover, 2002). Apparently, 
RING fingers function as scaffolds that bring other proteins together including E2s 
and substrates, thus facilitating ubiquitin transfer (Zheng et al., 2000). The RING 
finger E3s can form either single or multisubunit proteins of various sizes and 
composition. The multisubunit RING finger family of E3s is often subdivided into 
three major groups: APC (Anaphase Promoting Complex), SCF (Skp1-Cul1-F-box 
protein) and CBC (Cul2-Elongin B-Elongin C) (Petroski and Deshaies, 2005). The 
architecture and organization of E3s of the SCF and CBC group is similar in many 
ways. In both cases, a central 100-residue RING finger protein called Rbx1 acts as a 
scaffold that strongly interacts with a subunit belonging to the cullin protein family 
(Cul1/Cdc53 for the SCF and Cul2 in CBC) (Pickart, 2001a; Petroski and Deshaies, 
2005). Rbx1 also assists in recruiting the cognate E2s. The APC has a central RING 
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finger protein and displays a core ligase activity in conjunction with the ubiquitin 
conjugating enzymes Ubc4 or UbcH10 (Tang et al., 2001). This ubiquitin ligase is 
involved in degradation of cell cycle regulators such as cyclins and securin (Page and 
Hieter, 1999; Peters, 2006). 
The single subunit members of the RING finger E3s family recognize the 
ubiquitination signals in their specific substrates through domains that are structurally 
distinct from the RING finger. For the multisubunit RING finger E3s, substrate 
recognition is delegated in a different protein of the complex. For example, in the 
SCF E3s, substrate specific F-box proteins are recruited to SCF complexes through 
the adaptor protein Skp1which recognizes the eponymous F-box motif (Feldman et 
al., 1997; Skowyra et al., 1997; Deshaies, 1999; Pickart, 2001a). The SCF family is 
usually involved in the degradation of signal- and cell cycle-induced phosphorylated 
proteins (Deshaies, 1999). The SOCS-box protein, like the F-box protein in the SCF 
complex, is a variable component of the CBC complex and is thought to play a role in 
substrate recognition. VHL is a SOCS-box protein that was identified as the product 
of a gene that is frequently mutated in individuals with von Hippel–Lindau 
disease(Seizinger et al., 1988). The protein pVHL is recruited to the complex through 
interactions with the heterodimeric adaptor Elongin B/C (Pickart, 2001a). This 
complex is involved in degradation of HIF-1 (Maxwell et al., 1999; Kamura et al., 
2000; Ivan et al., 2001b; Jaakkola et al., 2001a). The existence of substrate-binding 
(F-box), cullin and adaptor protein families (Skp, elongins) together with other data 
indicates that E3 specificity can be reprogrammed, among other factors, by changing 
the identity of the substrate recognition subunit (Pickart, 2004; Petroski and Deshaies, 
2005). 
Examples of monomers or homodimers that contain both the RING finger 
domain and the substrate binding site in the same molecule include Mdm2 (that 
targets p53 for proteasomal degradation) (Lorick et al., 1999; Boyd et al., 2000; 
Geyer et al., 2000), Ubr1/E3 (Reiss and Hershko, 1990; Kwon et al., 1998), 
Parkin(Shimura et al., 2000) and c-Cbl (Joazeiro et al., 1999; Levkowitz et al., 1999). 
A third family of ubiquitin ligases, distinct from the HECT and RING 
families, has recently been identified: the U-box family (Hatakeyama and Nakayama, 
2003). Proteins belonging to this family contain a domain of ~70 aminoacids (the U-
box domain), similar to the RING finger, but lack the zinc-binding domain(Aravind 
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and Koonin, 2000). These proteins are able to mediate ubiquitination in conjunction 
with E1 and E2 and in the absence of other E3 components (Hatakeyama et al., 2001), 
suggesting that they possess ubiquitin ligase activity. This family of ubiquitin ligases 
has been implicated in the quality control system that underlies the cellular stress 
response to the intracellular accumulation of abnormal proteins (Hatakeyama and 
Nakayama, 2003).  
 
1.3.2 Diversity of degradation signals in the UPP 
 
Recognition of a protein substrate depends not only on the specificity of E3s 
and ancillary proteins, but also on intrinsic signals present in the substrate that 
determine its half-life and its susceptibility to ubiquitination and subsequent 
proteolysis (Ravid and Hochstrasser, 2008). In the late 80s, a set of short-lived 
substrates of the UPP was identified that contained specific aminoacids in its N-
terminus. This led to the idea that the stability of a protein was largely determined by 
the nature of its N-terminus aminoacid (Bachmair et al., 1986; Pickart, 2004). This 
rule, for protein susceptibility to ubiquitin-dependent degradation, is still known as 
the N-end rule. Subsequent studies revealed that, for some substrates, there are 
elements that are both necessary and sufficient to determine its ubiquitination 
(Varshavsky, 1997; Pickart, 2004). These elements that were eventually found in 
different locations in the protein structure are called degrons and can consist of 
various aminoacid motifs or sequences. 
Recognition by the N-end rule involves direct binding of the substrates to the 
ubiquitin ligase E3/Ubr1 (Varshavsky et al., 2000). E3 /Ubr1 has two N-end rule 
recognition sites: one for substrates with basic aminoacids at the NH2 terminal and 
another one for substrates with hydrophobic residues at the NH2 terminal (Reiss et al., 
1988; Kwon et al., 1998). A third site in the ligase is involved in targeting non-N-end 
rule substrates.  
One of the first aminoacid sequences to be identified in substrates that render 
them prone to UPP-dependent degradation was the destruction box found in mitotic 
cyclins and many other substrates of the APC (Glotzer et al., 1991; Deshaies, 1999; 
Koepp et al., 1999; Page and Hieter, 1999). The destruction box is a short sequence, 
RXALGXIXN, where the arginin and leucine residues are key determinants of 
specificity. This sequence, in the primary structure of the protein, appears to be 
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sufficient to recruit the appropriate E3s and to promote degradation of substrates. 
However, it also appears that the signal conformation may play a role in the efficient 
binding of E3s to substrates (Pickart, 2001a). Over the years, it also became apparent 
that phosphorylation is a common signal that targets proteins for degradation. Many 
of such proteins contain the so-called PEST regions. More recently, however, it 
became clear that, although such proteins are often degraded by the ubiquitin system, 
the PEST regions provide phosphorylation sites to regulate the accessibility of the 
degradation signals. 
Physiological recognition of degrons is not trivial and is subjected to a 
complex and highly coordinated sequence of events and interactions. Interactions 
between an E3 and a degron can be modulated by a variety of mechanisms, including 
posttranscriptional modifications, that serve to link ubiquitination to other cellular 
events (Deshaies, 1999; Deshaies and Ferrell, 2001). For example, the cell cycle 
needs to be precisely regulated and this involves the phosphorylation of Cyclin-
Dependent Kinases (CDKs) that is required to trigger ubiquitin-dependent 
degradation of CDK regulators. These regulators include (but are not limited to) the 
mammalian G1 cyclins D and E and the mammalian CDK inhibitor p27KIP1 
(Glickman and Ciechanover, 2002). Other regulatory proteins that need to be 
phosphorylated prior to ubiquitination include the transcriptional regulators IB and 
-catetin (Kornitzer and Ciechanover, 2000), as well as the NF-B precursor p105 
(Orian et al., 2000; Heissmeyer et al., 2001). 
Another important example of the posttranscriptional modification of a 
protein, that is particularly relevant in the context of neovascularization associated 
with AMD, is the degradation of the Hypoxia Inducible Factor-1 (HIF-1). Indeed, 
degradation of HIF-1 occurs continuously under normoxic conditions and requires 
prior oxygen-dependent hydroxylation of two specific proline residues that triggers 
recognition by a cullin-based E3 that has the von-Hippel Lindau (VHL) tumour 
suppressor protein as its specificity subunit (Ivan et al., 2001b; Jaakkola et al., 
2001a).  
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1.3.3 Degradation of ubiquitinated proteins 
 
The second major step in the UPP consists on the recognition and degradation 
of ubiquitinated substrates by the proteasome. The proteasome holoenzyme, also 
referred to as the 26S proteasome, is a 2.5 MDa complex made up of two copies. Each 
copy comprises, at least, 32 different subunits that are highly conserved among all 
eukaryotes. The overall structure can be divided into two major subcomplexes, the 
20S complex or core particle (CP) that contains the proteolytic activity and a 
regulatory particle (RP) also referred to as 19S cap complex or PA700 in mammals 
and μ particle in D. melanogaster (Glickman et al., 1999; Gorbea et al., 1999; Pickart 
and VanDemark, 2000) (Figure 5). The 20S particle is a cylindrical structure 
composed of four stacked heptameric rings. In yeast and higher eukaryotes, the rings 
are formed by 14 distinct subunits designated by  or . The active sites reside within 
the  subunits, which provide the catalytic N-terminal threonine residues. However, 
only three of the seven different  subunits have free N-terminal threonines, which 
means that the proteasome will present a total of 6 active sites (Groll et al., 1997). 
The active sites are buried in a central chamber isolated from the external solvent. 
Access to the catalytic core is very restricted and substrates must be unfolded to fit to 
an axial pore of 13 Aº in diameter (Pickart and VanDemark, 2000). The 
compartmentalization of the active sites inside a restricted chamber prevents 
indiscriminate degradation of proteins and confers some selectivity to the system. 
However, it is the 19S regulatory particle that confers both selectivity and specificity 
to the 26S proteasome activity. Biochemically, the 20S core presents only ATP-
independent peptidase activity. However, the assembled 26S proteasome presents a 
variety of activities and functions including polyubiquitin chain recognition and 
binding, nucleotidase activity, isopeptidase activity, unfoldase and endopeptidase 
activity (Groll et al., 1997; Glickman et al., 1999). Thus, binding of the 19S 
regulatory particle to the 20S proteasome confers selectivity and specificity of the 
proteasome towards ubiquitinated proteins.  
Indeed, ubiquitinated substrates need to be recognized, at a first stage, by 
specific protein subunits present in the 19S cap. Subsequently, the protein needs to be 
unfolded and fed to the catalytic chamber of the proteasome. As substrates are 
translocated through the central pore of the 20S core particle, ubiquitin is removed 
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and recycled for further use in other ubiquitination cycles (Glickman and 
Ciechanover, 2002; Pickart, 2004; Pickart and Cohen, 2004). These and other 
activities are all located in specific subunits present at the 19S caps and many of them 
require ATP that is used up by the ATPases present in these regulatory subunits.  
 
 
 
Figure 5 - Electron-microscopy image of a eukaryotic proteasome. Adapted from (Pickart and Cohen, 
2004). 
 
 
1.3.4 UPP and signal transduction 
 
In addition to a well established signal for protein degradation, ubiquitin is 
now recognized as an important regulator in many cellular processes, including (but 
not limited to) gene transcription, DNA repair and replication, virus budding, 
endocytosis and signal transduction (Haglund and Dikic, 2005; Welchman et al., 
2005; Kirkin and Dikic, 2007; Chen and Sun, 2009).  
Virtually all the signal transduction pathways in the cell are regulated by 
ubiquitin to some extent. Some of these pathways include the nuclear factor B (NF-
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B) (Chen, 2005; Chen and Sun, 2009), HIF-1 (Ivan et al., 2001a; Jaakkola et al., 
2001b), the mitogen-activated protein kinase (MAPK) pathway (Laine and Ronai, 
2005), the Notch pathway (Bray, 2006), the Wnt pathway (Logan and Nusse, 2004; 
Angers et al., 2006), and the transforming growth factor- (TGF-) pathway 
(Glasgow and Mishra, 2008), among others. 
Two of these pathways, the NF-B and HIF-1 pathways, are particularly 
relevant in the context of AMD. In fact, the altered activity of these transcription 
factors may underlie some of the pathophysiological changes associated with the 
development and progression of the disease, such as CNV and the increased 
inflammatory response. 
 
1.3.4.1 UPP and activation of NF-B 
 
NF-B is critical in the processing of a variety of proinflammatory signals, 
including the up-regulation of numerous cytokines (interleukin-1, 6, 8 and tumour 
necrosis factor - TNF), proangiogenic factors such as VEGF, inducible enzymes such 
as cyclo-oxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS), cell 
adhesion molecules (intercellular adhesion molecule-1 and vascular cellular adhesion 
molecule-1), stress proteins, anti-apoptotic factors (Bcl-2, survinin) and immune 
system receptors (Baldwin, 1996).  
NF-B is a generic term for a dimeric transcription factor formed by the 
hetero- or homodimerization of subunits belonging to a family of five members. 
Three of these proteins (p65, RelB and c-Rel) contain transactivation domains and 
two other proteins, p50 and p52, are expressed as the precursor proteins p105 (NF-
B1) and p100 (NF-B2), respectively (Ghosh and Hayden, 2008; Hayden and 
Ghosh, 2008). These precursors require posttranslational processing and do not 
contain transactivation domains. In fact, the UPP is also involved in the limited 
processing of the precursor protein p100 to yield the active subunit p52 (Chen, 2005; 
Ghosh and Hayden, 2008; Hayden and Ghosh, 2008). In quiescent cells, NF-B is 
located in the cytoplasm in an inactive form bound to a labile inhibitor molecule 
called IB, or other structurally related proteins (Ghosh and Hayden, 2008; Hayden 
and Ghosh, 2008). 
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NF-B can be activated in response to a variety of different stimuli including 
viruses, growth factors, antigens, radiation and chemotherapeutic drugs. However, the 
best-studied mechanism of activation of NF-B involves the response to the 
proinflammatory interleukin-1 (IL-1) (Figure 6). 
 The various pathways that lead to activation of NF-B appear to converge in 
the phosphorylation of IB by a cascade of complexes that include TAK1 (TGF--
Activated Kinase-1) and the IB Kinase complex (IKK). Activation of these kinases 
results in phosphorylation of IB (Karin and Ben-Neriah, 2000). The phosphorylated 
motif docks with a specific ubiquitin ligase complex, resulting in conjugation of 
ubiquitin to IB (Carter et al., 2005). Polyubiquitinated IB is then degraded by 
the 26S proteasome, NF-B is released and can translocate to the nucleus where it 
activates some of the genes described above (Maniatis, 1999; Karin and Ben-Neriah, 
2000) (Figure 6). The IKK complex is composed of three subunits: ,  and . It is 
the subunit  (IKK) that is responsible for IB phosphorylation and NF-B 
activation in response to proinflammatory stimuli, whereas IKK targets distinct 
cellular substrates in an alternative pathway for NF-B induction (Carter et al., 2005). 
The molecular events that activate the kinases that phosphorylate IB, 
targeting its degradation, are fairly complex and often involve different molecules that 
respond to different stimuli (Scheidereit, 2006; Ghosh and Hayden, 2008; Hayden and 
Ghosh, 2008). For example, when TNF- binds to TNF receptor-1, the receptor 
oligomerizes and associates with a complex that contains the ubiquitin ligase TRAF2 
(TNF-Receptor-Associated Factor-2). Working in association with the heterodimeric 
E2 Ubc13-MMS2, TRAF2 attaches Lys63-linked polyubiquitin chains to the receptor 
interacting protein (RIP) (Meylan and Tschopp, 2005). This triggers the TAK1 
complex to bind to the membrane-receptor complex through the Lys63-linked 
polyubiquitin chains and results in IB phosphorylation and its subsequent 
ubiquitination (Sun and Chen, 2004).  
In addition to its well-established role in targeting IB for degradation via 
Lys48-linked polyubiquitin chains, the UPP also regulates the NF-B pathway at 
multiple stages through nonproteolytic functions. In fact, as mentioned above, the 
assembly of Lys63-linked polyubiquitin chains regulates several steps in the 
activation of NF-B by serving as a signal to recruit proteins harbouring ubiquitin-
binding domains, thereby bringing together ubiquitinated proteins and ubiquitin 
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receptors, ultimately leading to IB degradation and NF-B activation (Chen and 
Sun, 2009). 
In addition, a recent study highlights the importance of linear 
polyubiquitination in NF-B activation (Tokunaga et al., 2009). The authors found 
that the LUBAC (linear ubiquitin chain assembly complex) ligase complex, composed 
of two RING finger proteins, conjugates a head-to-tail-linked polyubiquitin chain to 
NEMO, leading to NF-B activation (Tokunaga et al., 2009) .   
The switching off of this signalling cascade depends, among other factors, on 
deubiquitination. The importance of deubiquitination of proteins in switching off this 
signalling cascade is well illustrated by the human tumour condition cylindromatosis. 
Cylindromatosis is due to a mutation in the tumour suppressor CYLD, which cleaves 
Lys63-linked polyubiquitin chains from TRAF2 (Wilkinson, 2003). More recently, 
the protein A20 has emerged as a dual-catalysis enzyme that down-regulates the NF-
B system (Wertz et al., 2004). A20 cleaves the Lys63-linked polyubiquitin chains 
from RIP and adds Lys48-linked polyubiquitin chains to RIP, which results in its 
proteasomal degradation. In addition to deubiquitination, the termination of NF-B 
activity can also be achieved by degradation of its subunits. In fact, it was recently 
reported that PDLIM2 (PDZ and LIM domain 2) negatively regulates NF-B activity, 
acting as a nuclear ubiquitin E3 ligase that promotes p65 polyubiquitination and its 
subsequent degradation by the proteasome (Tanaka et al., 2007). 
There are a number of compounds that were shown to interfere with the 
activity of NF-B in cells. These include antioxidants, glucocorticosteroids, 
nonsteroidal anti-inflammatory drugs (NSAIDs), cytokines, peptides inhibiting the 
nuclear localization of NF-B and proteasome inhibitors such as MG132, PS-341 and 
PS-519. Stabilization of NF-B by proteasome inhibitors, for example, results in the 
blockade of NF-B activation and prevents the actions of NF-B within the cells 
(Palombella et al., 1994). An alternative method of controlling NF-B activity is via 
the modulation of phosphorylation of the DNA-binding subunits that can regulate the 
interactions between the transcription factor and regulatory proteins (Schmitz et al., 
2001). 
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Figure 6 – Regulation of the NF-B signalling pathway. Adapted from (Bhoj and Chen, 2009). 
 
 
1.3.4.2 UPP and degradation of HIF-1  
 
HIF is an oxygen-dependent transcription factor that plays a crucial role in the 
cell response to hypoxia (Pugh and Ratcliffe, 2003). This transcription factor induces 
the expression of more than 60 proteins involved in angiogenesis, glycolysis, glucose 
transport, erythropoiesis and others (Zagorska and Dulak, 2004).  
HIF is an -heterodimer, first recognized as a DNA-binding factor that 
mediates hypoxia-induced activity of the erythropoietin 3' enhancer (Semenza and 
Wang, 1992; Wang et al., 1995). Both HIF- and HIF- subunits exist as a series of 
isoforms encoded by distinct genetic loci. HIF-1 subunits are constitutive nuclear 
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proteins, whereas HIF- subunits are induced by hypoxia. Among three HIF-
aisoforms, HIF-1 and HIF-2  appear closely related and each one is able to interact 
with hypoxia response elements (HREs) to induce transcriptional activity (Pugh and 
Ratcliffe, 2003). In contrast, HIF-3 appears to be involved in negative regulation of 
the response, through an alternatively spliced transcript termed inhibitory PAS 
domain protein (Makino et al., 2001; Pugh and Ratcliffe, 2003). The abundance of 
HIF-1 subunits is mainly regulated by the rate of degradation. Under non-hypoxic 
(normoxia) conditions, HIF-1 is subject to oxygen-dependent prolyl hydroxylation 
(Ivan et al., 2001b; Jaakkola et al., 2001a), which is required for binding of the von 
Hippel-Lindau tumour suppressor protein (VHL), the recognition component of an 
ubiquitin ligase complex, which targets HIF-1 for ubiquitin-dependent proteasomal 
degradation (Maxwell et al., 1999) (Figure 7). HIF-1 contains two sites for 
hydroxylation, Pro402 and Pro564, within the oxygen-dependent degradation (ODD) 
domain and each site contains a conserved LXXLAP motif (Masson et al., 2001a). 
Ubiquitination of HIF-1, as of most proteins, requires primarily formation of 
a polyubiquitin chain through lysine 48 of ubiquitin. Subsequently, the 
polyubiquitinated HIF-1 needs to be translocated to the 26S proteasome for 
degradation. Under hypoxic conditions, oxygen becomes limiting for prolyl 
hydroxylase activity (Epstein et al., 2001) and ubiquitination of HIF-1 is inhibited 
(Sutter et al., 2000). As a result, HIF-1 accumulates, dimerizes with HIF-1, and 
activates transcription of target genes, including VEGF (Pugh and Ratcliffe, 2003). 
Although the classic model (described above) indicates that HIF-1  
ubiquitination and subsequent degradation only occurs under normoxic conditions, 
recent studies challenge this model by suggesting that HIF-1 can be ubiquitinated 
and degraded by the 26S proteasome even under hypoxic conditions (Cheng et al., 
2007; Koh et al., 2008). Interestingly, hypoxia induces SUMOylation of HIF-1, 
which promotes its binding to VHL, through a proline hydroxylation-independent 
mechanism, leading to its ubiquitination and degradation (Cheng et al., 2007). 
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Figure 7 - Mechanisms of HIF-1 regulation under aerobic and hypoxic conditions. Adapted from 
(Giaccia et al., 2003). 
 
 
The role of SUMOylation in the regulation of HIF-1 stability and activity 
under hypoxia remains controversial. Although SUMOylation has recently been 
shown to constitute a signal for ubiquitination and degradation of HIF-1 (Cheng et 
al., 2007), previous studies implicate SUMO in the activation of transcription through 
HIF-1 stabilization (Bae et al., 2004; Carbia-Nagashima et al., 2007). 
Further studies are therefore required to clarify this issue and to elucidate the 
multiple regulatory pathways that control HIF-1 under hypoxia. 
 
